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Introduction {#sec1}
============

Haploid cells serve as a powerful tool in forward and reverse genetic screening owing to their single-set chromosome feature ([@bib25]). To date, haploid embryonic stem cells (haESCs) have been achieved in many species assisted by Hoechst 33342 staining and fluorescence-activated cell sorting (FACS) ([@bib12], [@bib23]), which are important for recessive gene discovery ([@bib3], [@bib11]). Recent derivation of haploid somatic cell lines has facilitated lineage-specific genetic screening ([@bib6], [@bib4]). Nevertheless, all haploid cell cultures prefer to double back to diploids, the mechanism of which is still unclear. According to previous reports, the addition of cell cycle inhibitors ([@bib27], [@bib6]) or editing of specific genes ([@bib21], [@bib5]) can stabilize the haploid genome and reduce self-diploidization to some degree. However, no haploid cell line has been reported for an extraembryonic lineage. Trophoblast stem cells (TSCs) are one type of placental progenitor cell and are derived from blastocysts or the extraembryonic ectoderm of implantation embryos ([@bib29]). They can self-renew by relying on FGF4 and heparin (F4H *in vitro* and retain the potential to contribute exclusively to the placenta ([@bib19]). Therefore the derivation of TSCs provides considerable insight into the mechanisms that regulate extraembryonic lineage specification and placental development.

Previously, haploid cells were shown to be detectable in preimplantation blastocysts ([@bib15]) and implantation epiblast-stage embryos ([@bib24]), which indicated that haploid cells were reasonable in trophectoderm (TE) lineages. By regulating the expression of *Oct4* and *Cdx2*, embryonic stem cells (ESCs) and TSCs could switch from one to the other easily ([@bib17], [@bib32]). In addition, transcriptional induction reprograms somatic cells to functional TSCs ([@bib9], [@bib1]), suggesting that overexpression of TSC-specific transcription factors can commit cell fate to TE lineages. Hence, haESCs may have the potential to be converted to haploid-induced TSCs (haiTSCs) via overexpression of *Cdx2*.

Here, we overexpressed *Cdx2* in haESCs by using a Tet-On inducible system to alternate cell fate. We demonstrated that haiTSCs were generated from *p53*-deleted haESCs *in vitro* under defined conditions. haiTSCs maintained haploidy and contributed to the placenta in a chimeric experiment, proving that they potentially differentiated into functional trophoblast terminal cells. Then we performed a proof-of-concept screening in haiTSCs to identify key genes regulating spongiotrophoblast specification.

Results {#sec2}
=======

Overexpression of *Cdx2* Converts haESCs to TSCs {#sec2.1}
------------------------------------------------

To generate haiTSCs from haESCs by conversion *in vitro*, we adopted an inducible overexpression strategy. Parthenogenetic haESC lines were established from 129Sv/Jae background chemical-activated oocytes, and one line with a high percentage of haploid cells was chosen to perform subsequent experiments ([Figure 1](#fig1){ref-type="fig"}A). We then designed two *piggyBac* (PB) vectors to introduce Tet-On inducible *Cdx2* overexpression into haESCs: vector 1 had the rtTA (Tet-On Advanced transactivator) and *neomycin* selection genes, driven separately by an SV40 promoter, and vector 2 had the *Cdx2* and *puromycin* resistance genes, driven by a tetracycline response element with a minimal cytomegalovirus promoter ([Figure S1](#mmc1){ref-type="supplementary-material"}A). We transfected these two PB vectors and a PBase vector into haESCs by electroporation. Transfected cells were selected in 2i/L (inhibitor PD0325901, inhibitor CHIR99021, and mLif) medium ([@bib33]), supplemented with G418 (250 μg/mL) for 6 days. To evaluate the pluripotency of the transfected haESCs (which we termed OE-Cdx2 haESCs), we performed immunofluorescent staining of pluripotent markers and alkaline phosphatase (AP) staining. The results showed that OE-Cdx2 haESCs were positive not only for Oct4, Nanog, and SSEA1 ([Figure 1](#fig1){ref-type="fig"}B) but also for AP ([Figure 1](#fig1){ref-type="fig"}C), which demonstrated that vector insertion did not jeopardize haESC pluripotency. Thereafter we cultured newly sorted haploid OE-Cdx2 haESCs in standard TSC culture medium supplemented with doxycycline (Dox) and puromycin to induce *Cdx2* overexpression ([Figure 1](#fig1){ref-type="fig"}D). Obvious morphological change was observed 5 days after Dox induction, and many cells died during puromycin selection. Approximately 11 days after induction, typical TSC-like colonies were formed ([Figure 1](#fig1){ref-type="fig"}E) and expanded with trypsin, which meant that an inducible TSC (iTSC) line was established. Immunofluorescence results revealed that iTSCs expressed the TSC-specific markers Cdx2 and Eomes, rather than the ESC marker Oct4 ([Figure S2](#mmc1){ref-type="supplementary-material"}D). Quantitative PCR (qPCR) results further confirmed that iTSCs did not express pluripotent genes (*Oct4* and *Rex1*) relative to wild-type (WT) ESCs ([Figure 1](#fig1){ref-type="fig"}F) and showed similar expression levels of TSC markers (*Eomes* and *Elf5*) relative to WT-TSCs ([Figure 1](#fig1){ref-type="fig"}G). Therefore iTSCs were derived by conversion of haESCs *in vitro* through *Cdx2* overexpression.Figure 1Overexpression of *Cdx2* Converts haESCs to TSCs(A) DNA content analysis of haESCs. The percentage of 1n (G0/G1) peak was 50.2%.(B) Immunofluorescence staining of pluripotent markers (Oct4, Tetramethylrhodamine \[TRITC\] channel; Nanog and SSEA1, fluorescein isothiocyanate channel) in haESCs. DNA is stained with DAPI. Scale bar, 50 μm.(C) Alkaline phosphatase-stained haESCs cultured on mouse embryonic fibroblasts. Scale bar, 100 μm.(D) Schematic overview of iTSC derivation from haESCs via *Cdx2* overexpression.(E) The morphological changes of colonies during the conversion process. WT-TSCs are used as control. Scale bar, 100 μm.(F) The expression levels of pluripotent marker genes (*Oct4* and *Rex1*) in iTSCs, WT-TSCs, and WT-ESCs by qPCR. t test, \*\*\*p \< 0.001. Data are represented as mean ± SEM.(G) The expression levels of TSC marker genes (*Eomes* and *Elf5*) in iTSCs, WT-TSCs and WT-ESCs. t test, \*\*\*p \< 0.001. Data are represented as mean ± SEM.(H) DNA content analysis of iTSCs derived from haESCs. The results indicated that there were no haploid cells in the iTSCs.(I) Chromosome spreads of iTSCs. Each single cell spread had 40 chromosomes. Scale bar, 7.5 μm.See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

We utilized Hoechst 33342 staining and FACS to isolate haploid cells during conversion. After optimization, we first sorted the haploid cells on day 11 post conversion; the 1n peak (haploid cells) was 4.38% and was further expanded with good viability ([Figure S1](#mmc1){ref-type="supplementary-material"}B). There was no haploid cell left among the iTSCs according to the second round of sorting by FACS ([Figures 1](#fig1){ref-type="fig"}H and [S2](#mmc1){ref-type="supplementary-material"}C) and chromosome spread analysis ([Figure 1](#fig1){ref-type="fig"}I). We reasoned that different PB insertions might affect haploid maintenance ability; thus we randomly picked six subclones from among OE-Cdx2 haESCs. We genotyped the subclones, and the results suggested that all subclones carried *Cdx2* and rtTA ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Among the six subclones, \#1 and \#2 were stable in terms of haploid maintenance and were further assessed ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Although \#1 and \#2 carried a few insertions ([Figure S1](#mmc1){ref-type="supplementary-material"}D) and could be converted to typical iTSCs easily ([Figure S2](#mmc1){ref-type="supplementary-material"}B), neither of them could generate haiTSC lines ([Figure S2](#mmc1){ref-type="supplementary-material"}C). We reasoned that the nature of diploidization in haESCs during conversion hindered the derivation of haiTSCs.

Deletion of *p53* Facilitates Derivation of HaiTSCs {#sec2.2}
---------------------------------------------------

A previous study showed that *p53* gene deficiency could stabilize haploidy in mouse haESCs by promoting the viability and proliferation of haploid cells in daily culture ([@bib21]). To achieve haiTSCs in our OE-Cdx2 system, we knocked out *p53* in OE-Cdx2 haESCs through CRISPR/Cas9-mediated non-homologous end joining. We transfected plasmids carrying Cas9-GFP and two single guide RNAs (sgRNAs, targeting the third exon of *p53*) ([Figure S3](#mmc1){ref-type="supplementary-material"}B) into OE-Cdx2 haESCsubclone \#1, which had a high percentage of haploid cells ([Figure 2](#fig2){ref-type="fig"}A). Approximately 36 hr after transfection, haploid cells expressing Cas9-GFP were enriched by FACS ([Figure S3](#mmc1){ref-type="supplementary-material"}A). To address whether *p53* deletion occurred, we randomly picked four subclones (we termed them PO1, PO2, PO3, and PO4) and performed T7 endonuclease I (T7ENI) cleavage analysis. The results showed that all subclones underwent gene editing ([Figure S3](#mmc1){ref-type="supplementary-material"}C). Further sequencing results confirmed that all four subclones carried mutations with small deletions at the target sites ([Figure S3](#mmc1){ref-type="supplementary-material"}D). We also detected p53 at the protein level in PO1 and PO4 by western blot and found that the p53 protein was absent in these subclones ([Figure 2](#fig2){ref-type="fig"}B). Furthermore, we analyzed the expression levels of *p53*-related genes in PO1 and PO4 by qPCR relative to a WT-ESC line. *p53* and *P21* in PO1 and PO4 were downregulated, whereas other cell cycle genes, including *Reprimo*, *Cdk1,* and *Cyclin B*, exhibited no significant differences ([Figure 2](#fig2){ref-type="fig"}C). Taken together, the results indicated that *p53* deletion was successfully realized in OE-Cdx2 haESCs.Figure 2Deletion of p53 Facilitates Derivation of haiTSCs(A) Schematic diagram of the strategy to knock out p53 via the CRISPR/Cas9 system. The two sgRNAs are designed to target exon 3 of p53.(B) Western blot to detect p53 in PO1, PO4, and WT-haESCs. GAPDH is used as a loading control.(C) The expression levels of p53-related genes and cell-cycle-related genes (*p53*, *P21*, *Reprimo*, *Cdk1,* and *CyclinB*) in PO1, PO4, and WT-ESCs by qPCR. t test, \*\*\*p \< 0.001. Data are represented as mean ± SEM.(D) DNA content analysis of haiTSCs derived from the cell line PO4. The percentage of the 1n (G0/G1) peak was 70.4%. Diploid WT-TSCs are used as a control.(E) Chromosome spreads of haiTSCs and WT-TSCs. haiTSCs have a 20-chromosome set, whereas WT-TSCs show 40 chromosomes in a single cell. Scale bar, 7.5 μm.(F) TSC-specific CDCP1 antibody analysis of derived haiTSCs at first sorting. The percentage of CDCP1-positive cells is 39.7%.(G) Images of haiTSCs colonies on feeder cells and on Matrigel. Scale bar, 100 μm.(H) Immunofluorescence staining of TSC markers (Cdx2 and Eomes, fluorescein isothiocyanate channel) and pluripotent markers (Oct4, Tetramethylrhodamine \[TRITC\] channel) in haiTSCs. DNA is stained with DAPI. Scale bar, 50 μm.See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

To determine whether *p53* mutation could stabilize haploidy in OE-Cdx2 haESCs, we used a serum ESC medium without 2i ([@bib3]) to trigger severe diploidization. We cultured PO1, PO2, PO3, and PO4 separately in this serum ESC medium for five passages without sorting and found that the PO4 cell line maintained haploidy at a very high percentage relative to the other subclones ([Figure S3](#mmc1){ref-type="supplementary-material"}E). In another repeat trial, we cultured PO4 and \#1 in 2i/L medium; 40.2% of PO4 cells remained in the 1n peak (haESCs at G0/G1 phase), whereas the 1n peak percentage in \#1 was reduced to 16% during the same period ([Figure S3](#mmc1){ref-type="supplementary-material"}F). Given that PO4 with *p53* deletion maintained haploidy in a steady manner, we performed conversion with PO4 to derive haiTSCs with Dox and puromycin monitoring. After conversion for approximately 11 days and three subsequent rounds of haploidy purification by FACS ([Figure S3](#mmc1){ref-type="supplementary-material"}G), a haploid cell line was established and showed mostly one set of chromosomes by FACS ([Figure 2](#fig2){ref-type="fig"}D) and karyotype analysis ([Figure 2](#fig2){ref-type="fig"}E). To enrich authentic haiTSCs from these haploid derivatives, we purified them with the TSC-specific antibody CDCP1 ([@bib22]). The FACS results showed that approximately 39.7% of cells were already CDCP1 positive ([Figure 2](#fig2){ref-type="fig"}F); these cells were harvested and further cultured in either feeder or feeder-free culture systems with typical TSC colony morphology ([Figure 2](#fig2){ref-type="fig"}G). Immunofluorescence staining results revealed that haiTSCs expressed the TSC-specific markers Cdx2 and Eomes instead of the ESC marker Oct4 ([Figure 2](#fig2){ref-type="fig"}H).

Molecular Characterization and Differentiation Potentials of haiTSCs {#sec2.3}
--------------------------------------------------------------------

To assess the purity of haiTSCs after CDCP1-positive cell sorting, we passaged them several times and reanalyzed them with the CDCP1 antibody by FACS. CDCP1-positive cells remained at a high percentage (92.3%) in haiTSCs, which meant that haiTSCs could sustain TE identity during self-renewal ([Figure 3](#fig3){ref-type="fig"}A). The CDCP1-antibody-purified haiTSCs were expanded several times (three passages), and 15.3% of haploid cells remained ([Figure S4](#mmc1){ref-type="supplementary-material"}A), indicating that haiTSCs could maintain haploidy in a TSC-specific manner. qPCR further confirmed that the expression levels of TSC-specific genes (*Cdx2*, *Eomes*, *Elf5,* and *Tfap2c*) were high in haiTSCs and WT-TSCs ([Figure 3](#fig3){ref-type="fig"}B), whereas expression levels of pluripotent genes (*Oct4* and *Nanog*) in haiTSCs and WT-TSCs were much lower than those in haESCs and WT-ESCs ([Figure S4](#mmc1){ref-type="supplementary-material"}B). Western blot results also suggested that haiTSCs and WT-TSCs were positive for Cdx2 and Eomes relative to ESCs ([Figure 3](#fig3){ref-type="fig"}C). DNA-methylation-mediated gene regulation is crucial in the determination of specific transcription factors, which are extensively utilized to judge cell identities ([@bib32]). We analyzed the DNA methylation status of the *Oct4*, *Nanog,* and *Elf5* promoters in haiTSCs by performing bisulfite sequencing, with haESCs and WT-TSCs as controls. Results revealed that the *Elf5* promoter in haiTSCs was hypomethylated, whereas the *Oct4* and *Nanog* promoters in haiTSCs were hypermethylated ([Figure 3](#fig3){ref-type="fig"}D), which were consequent with previous report ([@bib16]). To elucidate the properties of haiTSCs on the transcriptome scale, we analyzed the global RNA levels of haiTSCs by performing RNA sequencing (RNA-seq). Cluster analysis revealed that haiTSCs resembled WT-TSCs but were distinct from either haESCs or WT-ESCs ([Figures 3](#fig3){ref-type="fig"}E and [S4](#mmc1){ref-type="supplementary-material"}C). As female WT-TSCs exhibit an inactive X chromosome in a single cell, we assessed the state of the sole X chromosome in haiTSCs by costaining for histone 3 lysine 27 trimethylation (H3K27me3) and Cdx2, with female and male WT-TSCs as controls. Only H3K27me3 in female WT-TSCs (XX) accumulated in the nuclei, visualized as bright spots; however, H3K27me3 in both haiTSCs and male WT-TSCs (XY) was located all over the nuclei ([Figure S4](#mmc1){ref-type="supplementary-material"}D), which indicated that the X chromosome in haiTSCs was active.Figure 3Identification of haiTSCs Properties and Differentiation Potential(A) FACS analysis of CDCP1-positive cells among established haiTSCs. haESCs are used as negative control.(B) The expression levels of TSC-specific marker genes (*Cdx2*, *Eomes*, *Elf5,* and *Tfap2c*) in haiTSCs, WT-TSCs, haESCs, and WT-ESCs. t test, \*\*p \< 0.01, \*\*\*p \< 0.001. Data are represented as mean ± SEM.(C) Western blot analysis of Eomes and Cdx2 in WT-ESCs, haESCs, WT-TSCs, and haiTSCs. GAPDH is used as a loading control.(D) DNA methylation status in the promoter regions of *Oct4*, *Nanog*, and *Elf5*. An haESCs line and a WT-TSCs line were used as controls.(E) Global gene expression cluster analysis of transcripts in WT-ESCs, haESCs, WT-TSCs, and haiTSCs.(F) Images of differentiated haiTSCs. Red arrow indicates syncytiotrophoblast cells, and yellow arrow indicates trophoblast giant cells. Scale bar, 100 μm.(G) Immunofluorescence staining of three trophoblast-lineage-specific markers, Tpbpa (fluorescein isothiocyanate channel), proliferin (Tetramethylrhodamine \[TRITC\] channel), and GCM1 (TRITC channel), in cells differentiated from haiTSCs *in vitro*. DNA is stained with DAPI. Scale bar, 25 μm.(H) Immunohistochemical (IHC) analysis of hemorrhagic lesions derived from haiTSCs. Fixed sample is IHC stained against the endothelial marker CD31 and the trophoblast marker Tfap2c.(I) Images of BF (top) and GFP (bottom) of a chimeric placenta following blastocyst injection of haiTSCs-eGFP cells. Scale bar, 2 mm.(J) Immunofluorescence staining of chimeric placenta following sectioning, with trophoblast-lineage-specific antibodies against proliferin and Tpbpa. Scale bar, 25 μm.See also [Figures S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}.

To test the differentiation potential of haiTSCs, we cultured the haiTSCs by withdrawing FGF4, heparin, and mouse embryonic fibroblasts *in vitro*. Obvious polyploidy trophoblast giant cells (TGCs) and syncytiotrophoblast (SyT) cells were observed ([Figure 3](#fig3){ref-type="fig"}F) and increased gradually ([Figure S5](#mmc1){ref-type="supplementary-material"}A). Immunofluorescence staining also revealed that the spongiotrophoblast-cell-specific marker Tpbpa, the TGC-specific marker proliferin, and the labyrinth-progenitor-specific marker Gcm1 were observed in differentiated cells from haiTSCs ([Figure 3](#fig3){ref-type="fig"}G). We analyzed trophoblast-lineage-specific gene expression levels of differentiated cells (4 days) from haiTSCs, iTSCs (diploid), and WT-TSCs by qPCR. Accordingly, differentiated cells from haiTSCs expressed all lineage-specific genes; in particular, *Ctsq*, *Prl2d1,* and *Tpbpa* increased significantly ([Figure S5](#mmc1){ref-type="supplementary-material"}B). Taken together, the results indicated that haiTSCs could differentiate into diverse trophoblast lineage cells *in vitro* by random differentiation. To investigate the *in vivo* differentiation potential of haiTSCs, we transplanted approximately 1 × 10^6^ haiTSCs into the testis of ICR mice, with WT-TSCs and ESCs as parallel controls. After 3 weeks, hemorrhagic lesions formed in the haiTSC and WT-TSC groups, whereas teratomas formed in the ESC group ([Figure S5](#mmc1){ref-type="supplementary-material"}C). Blood vessels with TGC invasion were confirmed in haiTSC-derived hemorrhagic lesions by immunohistochemical staining of Tfap2c and CD31 ([Figure 3](#fig3){ref-type="fig"}H), indicating that haiTSCs could mimic placental development by undergoing differentiation *in vivo*. Next, we microinjected GFP-labeled haiTSCs into blastocysts to test whether they could contribute to functional placenta. In the reconstructed blastocysts, the GFP-positive haiTSCs integrated into the TE instead of the inner cell mass (ICM), showing their trophoderm nature ([Figure S5](#mmc1){ref-type="supplementary-material"}D). To evaluate further development, the reconstructed embryos were transferred to the uteruses of pseudopregnant mice. On embryonic day 10.5 (E10.5), placentas and embryos were dissected from the pseudopregnant mice. We found GFP-positive cells contributing to the placentas ([Figure 3](#fig3){ref-type="fig"}I), and these cells were positive for proliferin and Tpbpa antibody staining according to fluorescence histology analysis ([Figure 3](#fig3){ref-type="fig"}J). Our findings revealed that haiTSCs could not only mimic placental development *in vivo* but also contributed to functional placenta, which are typical features of trophoblast progenitor cells.

*piggyBac* Transposon-Mediated High-Throughput Gene Trapping in haiTSCs {#sec2.4}
-----------------------------------------------------------------------

Haploid cells are easy to use for generating genome-wide homozygous mutant libraries via PB integration or virus infection ([@bib14]). To determine the feasibility of using haiTSCs in this process, approximately 1 × 10^7^ haiTSCs were transfected with PB-based gene trap vectors ([@bib12]) carrying a *puromycin* resistance (*Puro*^*r*^) gene ([Figure 4](#fig4){ref-type="fig"}A). After 4 days of puromycin selection, integrated haiTSCs with the *Puro*^*r*^ gene survived, and the control group mostly died ([Figure 4](#fig4){ref-type="fig"}B). We analyzed the mutant haiTSCs by FACS and found that 38.1% of haploid cells remained, suggesting high efficiency for obtaining homozygous mutant haiTSCs ([Figure 4](#fig4){ref-type="fig"}C). We harvested mutant haiTSCs and amplified the integration sites by performing splinkerette PCR. Obvious strands demonstrating integration were visualized ([Figure 4](#fig4){ref-type="fig"}D). We linked the products into plasmids and sequenced them by Sanger sequencing. In total, 50 different sites were addressed, of which 24 were located inside the gene body ([Figures S6](#mmc1){ref-type="supplementary-material"}A and S6B). These data indicate that haiTSCs could undergo gene manipulation and generate homozygous mutant libraries.Figure 4High-throughput Mutaion and Genetic screening in Derived haiTSCs(A) Schematic diagram of *piggyBac*-based gene trapping vectors. The PB vector contains: 5′ PB and 3′ PB, the inverted terminal repeats (ITRs); SA, splice acceptor; IRES, internal ribozyme entry site; Puro, the coding region of puromycin resistance gene; and PA, the poly(A) sequence; the PBase vector includes Plor2A, the promoter of pbase; the Pbase, the coding sequence region of Pbase; and PA.(B) haiTSCs transfected with *piggyBac*-based gene trapping vectors are selected by puromycin for 4 days. haiTSCs without transfection are used as a control. Scale bar, 100 μm. After selection, only transfected haiTSCs can survive.(C) DNA content analysis of haiTSCs after transfection and puromycin selection. The percentage of the 1n (G0/G1) peak was 38.1%.(D) Splinkerette PCR analysis of the transposition sites in the mutant haiTSCs. Each lane corresponds to one subclone; each strand corresponds to one PB integration.(E) Schematic diagram of screening for relevant genes in Tpbpa-positive cell. Random differentiation was performed with mutated and nonmutated haiTSCs cells independently for 3 days. Immunofluorescence staining (Tpbpa, left panel), FACS analysis, and sorting of Tpbpa-positive cells (right panel).See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

To apply haiTSCs in trophoblast lineage-specific genetic screening, we focused on key genes regulating spongiotrophoblast differentiation and utilized a specific antibody against Tpbpa ([@bib10]) as indicated. Briefly, we performed random differentiation in mutated haiTSCs, as previously described, and nonmutated haiTSCs separately for 3 days. Tpbpa-positive cells demonstrating spongiotrophoblast features were analyzed by immunostaining and FACS ([Figure 4](#fig4){ref-type="fig"}E). If the percentage of Tpbpa-positive cells increased significantly in the mutated haiTSCs group relative to the nonmutated haiTSCs group, the mutated Tpbpa-positive cells were harvested with a FACS-assisted antibody for further bioinformatics analysis. We performed this experiment several times and deep-sequenced two repeats with the Tpbpa-positive cells increasing group ([Figures 4](#fig4){ref-type="fig"}E, [S6](#mmc1){ref-type="supplementary-material"}C, and S6D). According to deep sequencing, approximately 4 million independent insertions across more than 20,000 genes were identified, of which 49.8% were derived from the sense orientation ([Figure 5](#fig5){ref-type="fig"}A). In addition, approximately 57% of the insertions were located in intragenetic regions (coding regions + intron + 5′/3′ UTR), whereas 39% of insertions landed in intergenetic regions ([Figure 5](#fig5){ref-type="fig"}B). Enrichment analysis with gene ontology databases showed that insertions preferred genes carrying specific functions for epigenetic modifications, such as repressing transcription factor binding and DNA methyltransferase activity ([Figure 5](#fig5){ref-type="fig"}C). Ten genes, including *Zfp704*, *Htra1*, and *Rsf1*, were identified ([Figure 5](#fig5){ref-type="fig"}D) due to both frequent insertions determined by PB screening and higher transcription activity measured from RNA-seq ([Figures 5](#fig5){ref-type="fig"}E and [S7](#mmc1){ref-type="supplementary-material"}). Of the top candidates, *Htra1* was chosen for further validation experiments in WT-TSCs ([Figure 5](#fig5){ref-type="fig"}E).Figure 5Bioinformatics Analysis of Integrations in haiTSCs(A) Proportion of insertional orientation (sense/antisense) after *piggyBac* integration. A total of 49.8% insertions were derived from the sense orientation.(B) Proportion of integration sites across various genomic regions: promoters (1 kb upstream of the transcription starting sites), 5′ UTR, exons, introns, 3′ UTR, and intergenic regions. Genome-wide PB transposon integration site analysis. Promoter region is identified as the 5-kb region upstream of a known gene.(C) Enriched gene ontologies of the top 100 genes with the most frequent insertions.(D) List of the top 10 genes with the most insertion sites.(E) Strand-specific coverage tracks of the gene Htra1 for the selected library (red). Gene model and chromosome coordinates are shown at the bottom.See also [Figure S7](#mmc1){ref-type="supplementary-material"}.

*Htra1* As a Blocker for Spongiotrophoblast Differentiation {#sec2.5}
-----------------------------------------------------------

To testify whether *Htra1* is an essential block against spongiotrophoblast differentiation in TSCs, we designed specific sgRNAs to knock out *Htra1* in WT-TSCs with the CRISPR/Cas9 system ([Figure 6](#fig6){ref-type="fig"}A). We transfected TSCs with a Cas9-sgRNAs vector (targeted), and control TSCs were transfected with an empty vector (mock). We performed random differentiation independently with the targeted TSCs (gene edited) and mock TSCs (non-gene edited) for 3 days. Spongiotrophoblast cells were observed by morphology ([Figure 6](#fig6){ref-type="fig"}B) analysis and Tpbpa antibody immunostaining ([Figure 6](#fig6){ref-type="fig"}C). According to a FACS analysis, the percentage of Tpbpa-positive cells in the targeted group significantly increased relative to the mock TSCs group ([Figure 6](#fig6){ref-type="fig"}D). In a parallel experiment, we analyzed the expression levels of trophoblast-lineage-specific markers in differentiated cells from the targeted and mock groups and found that the expression level of the spongiotrophoblast-specific marker Tpbpa in the targeted group increased significantly relative to the mock group, whereas the other two lineage markers in the targeted group decreased ([Figure 6](#fig6){ref-type="fig"}E). We tested the genotypes of targeted TSCs, and the results indicated that the cells carried a gene mutation in *Htra1* ([Figure 6](#fig6){ref-type="fig"}F). Thus *Htra1* plays a very important role in spongiotrophoblast specification.Figure 6Validation of Candidate Genes in a WT-TSC Differentiation Assay(A) Schematic diagram of the strategy to knock out *Htra1* in WT-TSCs using the CRISPR/Cas9 system.(B) Bright-field images of TSCs and differentiated cells from the non-gene-edited group (mock) and the gene edited group (targeted). Scale bar, 100 μm.(C) Immunofluorescence staining for Tpbpa (fluorescein isothiocyanate channel) in differentiated cells of the mock group and targeted group. DNA is stained with DAPI. Scale bar, 50 μm.(D) FACS analysis of Tpbpa-positive cells in WT-TSCs, the mock group (differentiation for 3 days), and the targeted group (differentiation for 3 days). The percentage of the targeted group is 22.5%, which is higher than that of the mock group (4.95%).(E) The expression levels of trophoblast-lineage-specific genes (*Tpbpa*, *Prl2c2,* and *Gcm1*) in differentiated cells (day 3) from the mock group and targeted group. t test, \*\*p \< 0.01. Data are represented as mean ± SEM.(F) *Htra1*-deleted genotypes in the targeted group.

Discussion {#sec3}
==========

In this study, we demonstrate that haiTSCs can be generated by the conversion of haESCs *in vitro* and maintain haploidy well, with the potential to differentiate into placental cells. We utilized a Dox-inducible Tet-On system to introduce *Cdx2* overexpression in haESCs, which was reported to be a key regulator of TE development ([@bib26]). Although a severe diploidization phenomenon was observed during ESC-TSC conversion, we adopted two strategies to establish haiTSCs: (1) knock out *p53* in the initial OE-Cdx2 haESCs to stabilize the haploid genome and (2) modify the TSC-specific culture system to promote cell fate alternation (including specific growth factors and inhibitors, TSC-specific antibody sorting, etc.). With these modifications, our haiTSCs maintained haploidy stably through *p53* gene deletion and guaranteed their potential in a subsequent gene trapping procedure. The results proved that the *p53* gene was a vital regulator of diploidization, which was consistent with a previous report ([@bib21]). However, the exact mechanism by which *p53* triggers diploidization remains unknown. In addition to gene modification, we optimized the TSC culture medium with a serum-free system, named TX medium ([@bib8]). Haploidy was better sustained in TX medium than in traditional TSC (70CM) medium ([@bib29]), potentially due to some unknown ingredients in serum (data not shown). In another parallel experiment, we attempted to derive haploid TSCs from haploid blastocysts in TX medium. However, no haploid cell line was established, mainly because embryonic TSCs tended to diploidize more severely. This leaves an open question: can haploid TSCs be established directly from haploid embryos and what is the mechanism underlying the thorough diploidization of haploid TE? We can compare the transcriptome differences between haiTSCs and haploid TEs from blastocysts in a future study.

As our haiTSCs were generated from haESCs *in vitro*, their purity and TSC properties needed to be confirmed. CDCP1 is a TSC-specific marker that has been widely used in research related to trophoblast cell fate determination ([@bib22], [@bib18]). Although our haiTSCs were established from an inducible system, a high percentage of CDCP1-positive cells was obtained ([Figure 3](#fig3){ref-type="fig"}A) after two rounds of FACS, and these cells maintained TSC properties. haiTSCs were maintained in a haploid state assisted by Hoechst 33342 purification and possessed differentiation potential to mimic placental development ([Figures S5](#mmc1){ref-type="supplementary-material"}C and [3](#fig3){ref-type="fig"}G), even contributing to functional placenta according to a chimeric experiment ([Figures 3](#fig3){ref-type="fig"}H and 3I). These features make haiTSCs perfect tools to evaluate the function of recessive genes related to placental development. Recently, the derivation of human TSCs was reported, raising extensive concerns regarding the study of placental abnormality in diseases associated with abortion ([@bib20]). In this study, haiTSCs served as a platform to screen essential placental development genes through reverse genetic screening. Abundant mutations were introduced into haiTSCs by the PB transposon ([Figures 4](#fig4){ref-type="fig"}D, [S6](#mmc1){ref-type="supplementary-material"}A and S6B), consistent with a previous report ([@bib31]). Stable maintenance of haploidy by haiTSCs facilitated the production of homozygous mutant libraries ([Figure 4](#fig4){ref-type="fig"}C), which are quite valuable for genetic screening. Therefore, in this study, we used haiTSCs in high-throughput screening to identify *Htra1* as a crucial gene regulating trophoblast specification. Early cell fate determination induces blastomeres to divide into the TE and ICM ([@bib30], [@bib28]); however, the molecular mechanism remains unclear. haiTSCs can also serve as a tool for the discovery of key genes regulating TE and ICM interactions.

In summary, we converted haESCs to haiTSCs by controlling the expression level of *Cdx2* with a Dox-inducible system. Although diploidization accompanied the conversion process, deletion of the *p53* gene reduced diploidization to some degree and facilitated the derivation of haiTSCs. haiTSCs not only showed standard TSC colonies and expressed TSC-specific genes but also held the potential to differentiate into placental cells. Therefore these haploid extraembryonic progenitor cells show great advantages for trophoblast lineage genetic screening.

Limitations of the Study {#sec3.1}
------------------------

In this experiment, we adapted p53 knockout strategy to establish authentic haploid extraembryonic cell line in a haploid nature. Whether the p53 knockout method could also benefit derivation of haploid TSCs from haploid blastocysts remains unknown. Meanwhile, p53 is an essential gene related to many important biological processes, including mitosis ([@bib2]) and cancer ([@bib13]). Strikingly, p53 knockout rescued the viability of tetraploid ESCs and enabled the generation of late-stage mouse tetraploid embryos ([@bib7]). Whether p53 knockout genotype would affect some unknown function of haiTSCs warrants more investigations.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Supplemental Information {#appsec2}
========================

Document S1. Transparent Methods, Figures S1--S7, and Table S1
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